Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03954431 · ClinicalTrials.gov registry record · NA

High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT)

A NA study of Breast Cancer, sponsored by University of Arizona.

Recruiting
Registry status
NA
Development phase
600
Enrollment target
1
Study location

NCT03954431 is a NA study of Breast Cancer that is actively recruiting participants, run by University of Arizona. The registered enrollment target is 600 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03954431, a NA study of Breast Cancer, is actively recruiting participants, sponsored by University of Arizona.

RECRUITING
Registry status
NA
Development phase
600 participants
Enrollment target
1
Study location

Study Summary

This study is being performed to find out if a new kind of breast imaging (called dedicated breast CT or BCT) can help doctors to see the small structures in breast tissue more clearly. The investigators also want to find out if using the BCT will provide a more accurate diagnosis of breast cancer.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Dedicated breast CT(BCT)

Study Locations (1)

Arizona

  • University of Arizona - Tucson

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2025-08-14
Est. Completion 2029-12
Phase NA

Sponsor

University of Arizona

349 total trials

What the Registry Record Tells You About NCT03954431

The ClinicalTrials.gov registry entry for NCT03954431 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (79% lower). The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Dedicated breast CT(BCT) is the first listed.

NCT03954431 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT03954431 about?

NCT03954431 is a clinical study titled "High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT)". This study is being performed to find out if a new kind of breast imaging (called dedicated breast CT or BCT) can help doctors to see the small structures in breast tissue more clearly. The investigators also want to find out if using the BCT will provide a more accurate diagnosis of breast cancer.

What is the current status of trial NCT03954431?

This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2025-08-14. Estimated completion is 2029-12.

What conditions does trial NCT03954431 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT03954431?

The interventions under investigation include: Dedicated breast CT(BCT) (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03954431?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03954431 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.